Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention

References

• Dangas G, Colombo A. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization. Am Heart J. 1999; 138: S16–S23
   Google Scholar
• Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost. 1993; 70: 119–23
   PubMed Web of Science ®Google Scholar
• Coller BS, Scudder LE, Beer J, Gold HK, Folts JD, Cavagnaro J, et al. Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents. Ann N Y Acad Sci. 1991; 614: 193–213
   PubMed Web of Science ®Google Scholar
• Coller BS. The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy. Eur Heart J 1995; 16: 11–5
   PubMedGoogle Scholar
• Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000; 7: 284–9
   Google Scholar
• Steinhubl SR. Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study. J Thromb Thrombolysis 2000; 9: 199–205
   Google Scholar
• Weiss, EJ, Bray, PF, Tayback, M, Schulman, SP, Kickler, TS, Becker, LC, , et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090–4.
   PubMed Web of Science ®Google Scholar
• Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism, The Framingham offspring study. Arteriosclerosis, Thrombosis. and Vascular Biology 1999; 19: 1142–7
   PubMed Web of Science ®Google Scholar
• Newman PJ, Derbes RS, Aster RH.. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989; 83: 1778–81
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol. 2000; 110: 965–7
   PubMed Web of Science ®Google Scholar
• Goldschmidt-Clermont PJ, Roos CM, Cooke GE. Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics. J Thromb and Thrombol 1999; 8: 89–103
   Google Scholar
• Lagercrantz J, Bergman M, Lundman P, Tornvall P, Hjemdahl P, Hamsten A, et al. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction. Blood Coagul and Fibrinol. 2003; 14: 749–53
   PubMed Web of Science ®Google Scholar
• Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013–8
   PubMed Web of Science ®Google Scholar
• Laule M, Cascorbi I, Stangl V, Bielecke C, Wernecke KD, Mrozikiewicz PM, et al. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 1999; 353: 708–12
   PubMed Web of Science ®Google Scholar
• Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF. The PlA2 polymorphism of integrin ß3 enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793–802
   PubMedGoogle Scholar
• Kastrati A., Schömig A., Seyfarth M., Koch W., Elezi S., Böttiger C., et al. PlA polymorphism of platelet glycoprotein iiia and risk of restenosis after coronary stent placement. Circulation 1999; 99: 1005–10
   PubMed Web of Science ®Google Scholar
• Walter DH, Schachinger V, Elsner M. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997; 350: 1217–9
   PubMed Web of Science ®Google Scholar
• Mamotte CD, van Bockxmeer FM, Taylor RR. Pla1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol. 1998; 82: 13–6
   Google Scholar
• Herrmann SM, Poirier O, Marques-Vidal P. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Thromb Haemost. 1997; 77: 1179–81
   Google Scholar
• Scaglione L, Bergerone S, Gaschino G, Imazio M, Maccagnani A, Gambino R, et al. Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest. 1998; 28: 385–8
   PubMed Web of Science ®Google Scholar